For example, it has been widely confirmed by in vitro and in vivo experiments that specific mutations of EGFR and KRAS may exactly drive the initiation and progression of lung adenocarcinoma, implying the key role of certain drivers for the tumorigenesis of lung adenocarcinoma19, 20. Here, EGFR is linked to lung adenocarcinoma.